Sort   by:  
 Page size 
ProteomicsHigh-resolution spatial proteomics of Plasmodium falciparum schizonts using hyperLOPIT and TMT-based mass spectrometry
This dataset contains a hyperLOPIT spatial proteomics experiment performed on Plasmodium falciparum to determine the subcellular localization of parasite proteins. Schizont-stage parasites were fractionated by density gradient centrifugation, and collected fractions were labelled with tandem mass ta...
ORGANISM(S): Homo sapiens (Human) Plasmodium falciparum (isolate 3D7) 
2026-06-01 | PXD070842 | Pride
UnknownApolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
Not available
S-EPMC5479565 | biostudies-literature
UnknownDesign and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.
Not available
S-EPMC4169732 | biostudies-literature
UnknownAssociation of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records.
Not available
S-EPMC4758131 | biostudies-literature
UnknownGenetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
Not available
S-EPMC5010878 | biostudies-literature
UnknownA second update on mapping the human genetic architecture of COVID-19.
Not available
S-EPMC10482689 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
UnknownHigher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC11872607 | biostudies-literature
UnknownMetformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861 | biostudies-literature
Sort   by:  
 Page size